The U.S. Food and Drug Administration (FDA) has approved an update to the prescribing information for Winrevair (sotatercept-csrk), an approved injection therapy for adults with pulmonary arterial hypertension (PAH) marketed by Merck. The most notable change in this update is the addition of a contraindication (a…
Discussion
After quite a bit of bittersweet contemplation, I’ve made the difficult decision to retire my column, “Blooming Hope.” Over the past five years, I’ve submitted 110 pieces reflecting on life with pulmonary hypertension (PH) and the aftermath of being a heart and lung transplant recipient. I will…
Discussion
“When the world is so complicated, the simple gift of friendship is within all of our hands.” — Maria Shriver If you or someone you love manages a rare disease like pulmonary hypertension (PH), you already know how deeply it touches every part of life. From everyday tasks to…
Discussion
A national database study found substantial variation in how clinicians manage people hospitalized with pulmonary arterial hypertension (PAH) who presented with shock, a life-threatening lack of blood flow to the body’s organs. Researchers identified 25 different initial treatment strategies involving vasoactive medications, drugs that adjust blood pressure and heart…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
